Subscribe to:
POZ magazine E-newsletters
POZ Personals Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents



Precious Stone

More Than Just a Number




Dodging Danger

Northern Disclosure

Ask For It By Name

Learning Latex

Yule Love ’Em

Catch of the Month

Cash Therapy

A Wealth of Trouble

Think Inside the Box

Baby Bonus

New Resistance Fighters




African in America

Windy City Blues

Unfine China

It’s a Wrap

Hot Dates-December 2007

Wake Up, India

Survey Says...

Clean Sweep

Look Elsewhere

Yesterday Once More

A Day Without “Day Without Art”

Medicine Man

Suspicious Minds




Editor's Letter-December 2007

Mailbox-December 2007


Most Talked About

Magic Johnson Accused of Faking HIV (42)

World AIDS Day: Your Feedback (22)

Guidelines Prediction: Start Treatment Earlier (blog) (19)

My First Facebook Demo (blog) (18)

Bone Marrow Transplant: Potential AIDS Cure? (9)

Obama Campaign Set to Boost Domestic HIV/AIDS Funding (8)

Most Popular Lessons

The HIV Life Cycle

Herpes Simplex Virus

Human Papilloma Virus (HPV)

Shingles

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)


NEW! Scroll down to comment on this story.


emailrssprint

December 2007


Cash Therapy

by Nicole Joseph

Money versus biology in HIV treatment effectiveness—guess which wins?

Can being poor affect the way you respond to HIV treatment? Yes, say researchers from the Harvard School of Public Health. In a recent study, they determined that a person’s socioeconomic position could influence the effectiveness of initial therapy—suggesting that the success of antiretroviral medication isn’t a strictly biological matter.

“In this study, we looked at a social factor to see if it would be a predictor [of] whether or not a patient is going to respond to treatment,” says Dr. Linda Marc, lead author of the study and now a lecturer at the Yale School of Public Health. “Poorer people have more daily hassles—for example, they might not have 50 cents to take the bus—[and] stress is known to influence the immune system.”

Since one or some combination of three traits—income, education and occupation—is generally used to define socioeconomic status, Marc’s group chose to examine the relationship between a person’s educational background and the success of antiretroviral therapy. They examined HIV-positive people who’d never taken meds before; after starting treatment, those with lower education levels reached initial regimen failure sooner than study participants who had college or graduate degrees. Current IV-drug-using subjects, as well as black participants—two groups who statistically may have lower levels of schooling—were also more likely to experience first-regimen failure than others.

Doctors and medical experts need to expand traditional biology-based research to take a closer look at the social factors affecting their patients, recommends Marc, who adds that “the findings support the development of health promotion programs focusing on psychological and behavioral aspects associated with HIV treatments.” Marc also says pharmaceutical companies should consider putting money toward these research areas—and soon.     

NEW! Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team review all comments before they are posted. Please do not include either ":" or "@" in your comment.)

| Posting Rules

Previous Comments:

  comments 1 - 3 (of 3 total)    

Jerry, , 2007-12-05 19:31:38
Interesting, so I read article in Journal Psychosomatic Research, Aug 2007. 96% of patients took cocktails as prescribed, yet, there was still poorer treatment response in the lower educated groups. In addition, the lower educated who had HIGH confidence in the effectiveness of treatments and their ability to take medications, responded better than under-educated without these traits. Status-related stress clearly impacted immune functioning. Thus, programs can be designed to increase CD4.

Nannette Rivera, NYC, 2007-11-30 10:30:46
I'm 37 year old and I became HIV+ in 1982, I was 12. That's the time when it was just Aids not HIV and there was no cure or treatment. I didn't start treatment unto I got pregnant with my daughter at 24 years old. After I start it treatment and my daughter was born I couln't stop treatment because every time I try I got sick but before I start it treatment I never got sick. I do think that a state of mind got something to do with your health wether you are HIV or not.

A Study??, , 2007-11-29 20:01:58
That's a given! you don't need a study to tell me my health is suffering due to my financial situation. I'm so stressed I don't eat or sleep most days, along with the depression which adds to it!

comments 1 - 3 (of 3 total)    

[Go to top]

Get Started
Get Answers
What to do if you've just been diagnosed
How to find a support system
Things you should know before starting treatment
How to handle side effects and other concerns
How to tell someone you have HIV/AIDS

Talk to Us
Weekly Poll
Question: Would legalizing prostitution reduce the spread of HIV?
Yes
No
I don't know.

Monthly Poll
Question: Do you believe that prisoners receive adequate health care?
Yes
No
I don't know.

Surveys
Tell us about your overall health habits.

Tell us when and to whom you disclose your status.

more surveys
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertise/contact us | site map]
© 2008 Smart + Strong. All Rights Reserved. Terms of use and Your privacy